Insights - In last week’s biotech recap, and again at PropThink.com this week, we outlined some key support levels for the S&P 500 (SPX or SPY), explaining … Continue Reading
Read NowInsights - FDA put the breaks on Repros (RPRX) on Friday when it indicated that an upcoming meeting would not be the pre-NDA meeting investors expected.
Read NowInsights - Tekmira (TKMR) revealed the first data for TKM-HBV publicly on Wednesday at a medical conference. Though early, Mr. Fink likes what he sees.
Read NowInsights - Multiple reasons for support, 1800 on the SPX/SPY is an interesting level to watch. No, it's not time to panic.
Read NowInsights - AbbVie (ABBV) is walking back its plan to buy Shire Plc (SHPG) on concerns over new U.S. laws making it harder for American companies to lower taxes through inversions, or … Continue Reading
Read NowInsights - Johnson & Johnson (JNJ) reported third quarter earnings on Tuesday and $18.5 billion in revenue (+5.1% over the quarter a year ago), with net earnings of $4.7 billion … Continue Reading
Read NowInsights - At a medical meeting this week Alnylam Pharmaceuticals (ALNY) reported six-month data from an ongoing study of patisiran (ALN-TTR02) in the rare disorder TTR-mediated amyloidosis (ATTR) in patients with … Continue Reading
Read Now
